Futura Medical (LON:FUM) Stock Falls 11.1% – Here’s Why

Futura Medical plc (LON:FUM)’s share price was down 11.1% during mid-day trading on Friday. The company traded as low as GBX 0.16 and last traded at GBX 0.16. 18,978,887 shares changed hands during mid-day trading, an increase of 79% from the average daily volume of 10,588,297 shares. The stock had previously closed at GBX 0.18.

Futura Medical Stock Performance

The company’s 50-day moving average is GBX 0.27 and its 200 day moving average is GBX 0.53. The company has a market capitalization of £2.37 million, a PE ratio of -0.20 and a beta of 0.02.

Futura Medical (LON:FUM) last issued its earnings results on Tuesday, September 1st. The company reported GBX (0.20) earnings per share (EPS) for the quarter. Futura Medical had a negative return on equity of 152.42% and a negative net margin of 158.21%. On average, analysts forecast that Futura Medical plc will post 2.85 EPS for the current fiscal year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.